We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AGL Agilon Health inc

0.02 (0.33%)
Feb 23 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Agilon Health inc AGL NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
0.02 0.33% 6.15 19:00:00
Open Price Low Price High Price Close Price Previous Close
6.09 6.06 6.49 6.27 6.13
more quote information »

Recent News

Date Time Source Heading
2/21/202415:00BWagilon health to Participate in the 44th Annual Cowen Health..
2/09/202415:00BWagilon health Sets Date to Report Fourth Quarter and Full..
2/08/202415:07EDGAR2Form 8-K - Current report
2/08/202415:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/08/202415:00BWagilon health Announces Chief Medical Officer Transition
1/05/202405:08EDGAR2Form 8-K - Current report
1/05/202405:05BWagilon health Announces Tim Bensley to Retire as CFO
1/05/202405:02EDGAR2Form 8-K - Current report
1/05/202405:00BWagilon health Provides 2023 Guidance Update, Initial 2024..
12/21/202315:00BWagilon health to Participate in the 42nd Annual J.P. Morgan..
12/01/202307:35GLOBESmall-Cap Growth Virtual Investor Conference: Presentations..
11/07/202315:00BWagilon health to Participate in Wolfe Research Healthcare..
11/02/202315:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202315:01EDGAR2Form 8-K - Current report
11/02/202315:00BWagilon health Reports Third Quarter 2023 Results
11/01/202315:00BWagilon health Announces Sale of MDX Hawaii
10/23/202315:10BWagilon health Reports ACO REACH Model Results for 2022..
10/11/202315:30BWagilon health Sets Date to Report Third Quarter 2023..
9/14/202315:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/13/202317:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/12/202315:36EDGAR2Form 144 - Report of proposed sale of securities
9/08/202309:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
8/24/202315:01BWagilon health to Participate in Upcoming Investor..
8/18/202315:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/18/202315:17EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/16/202315:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/16/202315:15EDGAR2Form 8-K - Current report
8/08/202316:09EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
8/03/202315:04EDGAR2Form 8-K - Current report
8/03/202315:00BWagilon health Reports Second Quarter 2023 Results
7/14/202315:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/12/202315:05BWagilon health Sets Date to Report Second Quarter 2023..
6/26/202307:30BWagilon health Names Silvana Battaglia to Board of Directors
6/22/202308:00BWPinehurst Medical Clinic and agilon health Partner with COPE..
5/31/202307:30BWCenter for Primary Care (CPC) Forms Long-term Partnership..
5/25/202315:30BWagilon health to Participate at 43rd Annual William Blair..
5/16/202301:15BWagilon health Announces Pricing of Secondary Offering
5/15/202315:18BWagilon health Announces Secondary Offering and Share..
5/09/202315:01BWagilon health Reports First Quarter 2023 Results
5/03/202315:15BWagilon health to Participate in Upcoming Investor..
5/02/202307:30BWCatalyst Health Network, Largest Network of Independent..
4/20/202315:21BWagilon health Sets Date to Report First Quarter 2023..
3/30/202306:30BWPremier Health Forms Long-term Partnership with agilon..
3/15/202315:15BWagilon health to Host Investor Day on March 30
3/01/202315:01BWagilon health Reports Fourth Quarter and Fiscal Year 2022..
3/01/202315:00BWagilon health Announces Acquisition of mphrX, a Leading..
2/28/202307:30BWFamily Practice Center (FPC) Partners with agilon health to..

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |